Literature DB >> 12082030

Membrane-type matrix metalloproteinases mediate curcumin-induced cell migration in non-tumorigenic colon epithelial cells differing in Apc genotype.

Jenifer I Fenton1, Margaret S Wolff, Michael W Orth, Norman G Hord.   

Abstract

Colonic epithelial cell migration is required for normal differentiated cell function. This migratory phenotype is dependent upon wild-type adenomatous polyposis coli (Apc) expression. Non-tumorigenic murine colon epithelial cell lines with distinct Apc genotypes, i.e. young adult mouse colon (YAMC; Apc(+/+)) and immortomouse/Min colon epithelial (IMCE; Apc(Min/+) cells) were used to assess the association between the Apc genotype, cell motility and matrix metalloproteinase (MMP) activity. Cells were treated with epidermal growth factor (EGF; 1, 10 and 25 ng/ml), hepatocyte growth factor (HGF; 1, 10 and 25 ng/ml) and/or curcumin (0.1-100 microM). EGF (25 ng/ml) and HGF (25 ng/ml) induced a greater migratory response in YAMC compared with IMCE cells after 24 h (P < 0.05). Treatment with curcumin induced a greater or equivalent migratory response in IMCE than YAMC cells. When migrating cells were treated with Ilomastat (MMP inhibitor), migration was inhibited in both cell types. High concentrations of Ilomastat (25 and 50 microM) inhibited migration in both cell types, while low concentrations (10 microM) inhibited HGF-induced IMCE migration. Curcumin-induced migration was inhibited in both cell types at the highest concentration of Ilomastat (50 microM). Immuno-localization analysis of membrane type-1 (MT1)-MMP indicated that migration is associated with the redistribution of this protein from the endoplasmic reticulum to the plasma membrane. Addition of neutralizing polyclonal antibodies against MT1-MMP or a mixture of MT1, 2- and 3-MMPs demonstrated partial or complete inhibition of cell migration in both cell types, respectively. The data provide the first evidence that migration in non-tumorigenic murine colon epithelial cells is: (i) inducible by EGF and HGF in an Apc genotype-dependent manner, (ii) dependent on MT-MMP activity and (iii) inducible by curcumin in an Apc genotype-independent manner. The data suggest a potential mechanism by which curcumin may induce cells heterozygous for Apc to overcome defective cell migration, a phenotype associated with cell differentiation and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12082030     DOI: 10.1093/carcin/23.6.1065

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  Characterization of aneuploid populations with trisomy 7 and 20 derived from diploid human colonic epithelial cells.

Authors:  Peter Ly; Ugur Eskiocak; Sang B Kim; Andres I Roig; Suzie K Hight; Dypti R Lulla; Ying S Zou; Kimberly Batten; Woodring E Wright; Jerry W Shay
Journal:  Neoplasia       Date:  2011-04       Impact factor: 5.715

Review 2.  Adenomatous Polyposis Coli (APC) in cell migration.

Authors:  Xingyuan Fang; Tatyana M Svitkina
Journal:  Eur J Cell Biol       Date:  2022-04-22       Impact factor: 6.020

3.  Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.

Authors:  Charlotte Labalette; Yann Nouët; Florence Levillayer; Sabine Colnot; Ju Chen; Valere Claude; Michel Huerre; Christine Perret; Marie-Annick Buendia; Yu Wei
Journal:  PLoS One       Date:  2010-04-28       Impact factor: 3.240

4.  Got black swimming dots in your cell culture? Identification of Achromobacter as a novel cell culture contaminant.

Authors:  Jennifer Sue Gray; Janette Marie Birmingham; Jenifer Imig Fenton
Journal:  Biologicals       Date:  2009-11-18       Impact factor: 1.856

5.  Novel mechanism for obesity-induced colon cancer progression.

Authors:  Janette M Birmingham; Julia V Busik; Fay M Hansen-Smith; Jenifer I Fenton
Journal:  Carcinogenesis       Date:  2009-02-12       Impact factor: 4.944

6.  Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice.

Authors:  Owen J Sansom; Fiona C Mansergh; Martin J Evans; Julie A Wilkins; Alan R Clarke
Journal:  Gut       Date:  2007-02-13       Impact factor: 23.059

7.  Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of Curcuma longa-in Cancer Cells.

Authors:  Edna Ooko; Onat Kadioglu; Henry J Greten; Thomas Efferth
Journal:  Front Pharmacol       Date:  2017-02-02       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.